Menu
Recruiting NCT07247409

Establishment of Hong Kong Diabesity Register

Observational Diabesity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No Intervention: Observational Cohort.
Who it may be relevant to
Registry conditions: Diabesity. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Hong Kong
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

All participants of the Diabesity Register will receive structured assessment by nurses guided by the JADE portal at baseline including eye, feet, blood and urine examination with evaluation of BMI, blood pressure, HbA1c, lipid profile, renal and liver function tests, urine for albumin-creatinine ratio. All patients will return at 3-year for a repeat assessment of physical and psychological health, as well as changes over time.

Interventions

  • Other No Intervention: Observational Cohort
    It is an registry so no intervention will be used.

Primary outcome measures

  • A composite of incidence [Time frame: 3 years]
Secondary outcome measures (6)
  • Incidence of diabetic mellitus retinopathy [Time frame: 3 years]
  • Incidence of diabetic mellitus nephropathy [Time frame: 3 years]
  • Incidence of diabetic mellitus neuropathy [Time frame: 3 years]
  • Incidence of myocardial infarction [Time frame: 3 years]
  • Incidence of stroke [Time frame: 3 years]
  • Incidence of peripheral artery disease [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • Type 2 diabetes;
  • Obesity reaching action level as defined as body mass index (BMI) 27.5 kg/m2 and/or waist circumference (WC) 80cm in women and 90cm in men;
  • Age between 18 and 50 years;
  • Able to conversate with smartphone technology and web-based program.
  • Able to read Chinese and communicate using Chinese.

Exclusion criteria

  • Type 1 diabetes;
  • Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration;
  • Life expectancy less than 12 months;
  • Any medical illness or condition as judged by the investigators as ineligible to participate the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Hong Kong · 1 center
  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward — Hong Kong

Identifiers

NCT: NCT07247409 · CRE 2025.324 register

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗